{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/86324"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/86324","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Mechanisms of mTOR Signal Transduction Regulating Cell Growth and Differentiation","abstract":"In chapter V, among the list of microRNAs from the microarray analysis, we focus on the muscle-specific miR-1, which is up-regulated during differentiation. mTOR is essential for miR-1 expression in C2C12 cells and in vivo in regenerating myofibers. It regulates the transcription of miR-1 through its upstream enhancers, and this regulation is at least partially mediated by the myogenic transcription factor MyoD. To delineate the pathway downstream of mTOR-miR-1 in myogenesis, we have tested the reported miR-1 target in skeletal muscle-HDAC4, and separately, a myogenic factor that is reportedly inhibited by HDACs-follistatin. Anti-miR-1 LNA dampens follistatin mRNA level, which is rescued by HDAC inhibitor trichostatin A (TSA). Concurrently, anti-miR-1 LNA also inhibits myotube fusion, which could be rescued by either introducing recombinant follistatin, or inducing the expression of endogenous follistatin through TSA. These data strongly support an HDAC4-follistatin pathway as the functional target of miR-1 in myogenesis. Importantly, rapamycin enhances the expression of HDAC4 and decreases follistatin mRNA level during myoblast differentiation. Furthermore, myotube growth and maturation, which requires a late-stage myogenic fusion after nascent myotube formation, is rescued by either follistatin or TSA from rapamycin inhibition both in C2C12 cells and in skeletal muscle regeneration in vivo, suggesting that follistatin is most likely the long-sought fusion factor regulated by mTOR in muscle growth. Taken together, this study has revealed for the first time a link between mTOR signaling and microRNA, and identified a novel mTOR-miR-1-HDAC4-follistatin pathway that regulates myocyte fusion critical for myotube maturation and skeletal muscle growth.","abstract_html":"In chapter V, among the list of microRNAs from the microarray analysis, we focus on the muscle-specific miR-1, which is up-regulated during differentiation. mTOR is essential for miR-1 expression in C2C12 cells and in vivo in regenerating myofibers. It regulates the transcription of miR-1 through its upstream enhancers, and this regulation is at least partially mediated by the myogenic transcription factor MyoD. To delineate the pathway downstream of mTOR-miR-1 in myogenesis, we have tested the reported miR-1 target in skeletal muscle-HDAC4, and separately, a myogenic factor that is reportedly inhibited by HDACs-follistatin. Anti-miR-1 LNA dampens follistatin mRNA level, which is rescued by HDAC inhibitor trichostatin A (TSA). Concurrently, anti-miR-1 LNA also inhibits myotube fusion, which could be rescued by either introducing recombinant follistatin, or inducing the expression of endogenous follistatin through TSA. These data strongly support an HDAC4-follistatin pathway as the functional target of miR-1 in myogenesis. Importantly, rapamycin enhances the expression of HDAC4 and decreases follistatin mRNA level during myoblast differentiation. Furthermore, myotube growth and maturation, which requires a late-stage myogenic fusion after nascent myotube formation, is rescued by either follistatin or TSA from rapamycin inhibition both in C2C12 cells and in skeletal muscle regeneration in vivo, suggesting that follistatin is most likely the long-sought fusion factor regulated by mTOR in muscle growth. Taken together, this study has revealed for the first time a link between mTOR signaling and microRNA, and identified a novel mTOR-miR-1-HDAC4-follistatin pathway that regulates myocyte fusion critical for myotube maturation and skeletal muscle growth.","abstract_has_math":false,"creators":["Sun, Yuting"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Cell and Developmental Biology","degree_department":null,"school":null,"contributors":["Belmont, Andrew S.","Chen, Jie"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"10000-01-01","date_published":"10000-01-01","updated_at":"2026-07-22T22:26:27Z","subjects":["Biology, Cell"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(MiAaPQ)AAI3363097"],"render_values":[{"text":"(MiAaPQ)AAI3363097","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/86324","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Belmont, Andrew S.","Chen, Jie"]},{"key":"dc:creator","label":"Author","values":["Sun, Yuting"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["10000-01-01","2015-09-28T15:03:21Z","2009"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Cell and Developmental Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology, Cell"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/86324","(MiAaPQ)AAI3363097"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["In chapter V, among the list of microRNAs from the microarray analysis, we focus on the muscle-specific miR-1, which is up-regulated during differentiation. mTOR is essential for miR-1 expression in C2C12 cells and in vivo in regenerating myofibers. It regulates the transcription of miR-1 through its upstream enhancers, and this regulation is at least partially mediated by the myogenic transcription factor MyoD. To delineate the pathway downstream of mTOR-miR-1 in myogenesis, we have tested the reported miR-1 target in skeletal muscle-HDAC4, and separately, a myogenic factor that is reportedly inhibited by HDACs-follistatin. Anti-miR-1 LNA dampens follistatin mRNA level, which is rescued by HDAC inhibitor trichostatin A (TSA). Concurrently, anti-miR-1 LNA also inhibits myotube fusion, which could be rescued by either introducing recombinant follistatin, or inducing the expression of endogenous follistatin through TSA. These data strongly support an HDAC4-follistatin pathway as the functional target of miR-1 in myogenesis. Importantly, rapamycin enhances the expression of HDAC4 and decreases follistatin mRNA level during myoblast differentiation. Furthermore, myotube growth and maturation, which requires a late-stage myogenic fusion after nascent myotube formation, is rescued by either follistatin or TSA from rapamycin inhibition both in C2C12 cells and in skeletal muscle regeneration in vivo, suggesting that follistatin is most likely the long-sought fusion factor regulated by mTOR in muscle growth. Taken together, this study has revealed for the first time a link between mTOR signaling and microRNA, and identified a novel mTOR-miR-1-HDAC4-follistatin pathway that regulates myocyte fusion critical for myotube maturation and skeletal muscle growth.","Made available in DSpace on 2015-09-28T15:03:21Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3363097.pdf: 2136791 bytes, checksum: c8f4a54de7f572768b019210ecb6131e (MD5) Previous issue date: 2009","Embargo set by: Seth Robbins for item 87605 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","131 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2009."]},{"key":"dc:title","label":"Title","values":["Mechanisms of mTOR Signal Transduction Regulating Cell Growth and Differentiation"]}]}],"canonical_facts":{"dc:contributor":["Belmont, Andrew S.","Chen, Jie"],"dc:creator":["Sun, Yuting"],"dc:date":["10000-01-01","2015-09-28T15:03:21Z","2009"],"dc:description":["In chapter V, among the list of microRNAs from the microarray analysis, we focus on the muscle-specific miR-1, which is up-regulated during differentiation. mTOR is essential for miR-1 expression in C2C12 cells and in vivo in regenerating myofibers. It regulates the transcription of miR-1 through its upstream enhancers, and this regulation is at least partially mediated by the myogenic transcription factor MyoD. To delineate the pathway downstream of mTOR-miR-1 in myogenesis, we have tested the reported miR-1 target in skeletal muscle-HDAC4, and separately, a myogenic factor that is reportedly inhibited by HDACs-follistatin. Anti-miR-1 LNA dampens follistatin mRNA level, which is rescued by HDAC inhibitor trichostatin A (TSA). Concurrently, anti-miR-1 LNA also inhibits myotube fusion, which could be rescued by either introducing recombinant follistatin, or inducing the expression of endogenous follistatin through TSA. These data strongly support an HDAC4-follistatin pathway as the functional target of miR-1 in myogenesis. Importantly, rapamycin enhances the expression of HDAC4 and decreases follistatin mRNA level during myoblast differentiation. Furthermore, myotube growth and maturation, which requires a late-stage myogenic fusion after nascent myotube formation, is rescued by either follistatin or TSA from rapamycin inhibition both in C2C12 cells and in skeletal muscle regeneration in vivo, suggesting that follistatin is most likely the long-sought fusion factor regulated by mTOR in muscle growth. Taken together, this study has revealed for the first time a link between mTOR signaling and microRNA, and identified a novel mTOR-miR-1-HDAC4-follistatin pathway that regulates myocyte fusion critical for myotube maturation and skeletal muscle growth.","Made available in DSpace on 2015-09-28T15:03:21Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3363097.pdf: 2136791 bytes, checksum: c8f4a54de7f572768b019210ecb6131e (MD5) Previous issue date: 2009","Embargo set by: Seth Robbins for item 87605 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","131 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2009."],"dc:identifier":["http://hdl.handle.net/2142/86324","(MiAaPQ)AAI3363097"],"dc:language":["eng"],"dc:subject":["Biology, Cell"],"dc:title":["Mechanisms of mTOR Signal Transduction Regulating Cell Growth and Differentiation"],"dc:type":["text"],"thesis:degree_discipline":["Cell and Developmental Biology"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:27Z"}